GENEPLAZA
Board
2 directors, no change since 2024Director (not named in the articles)
since 04-04-2018
listed in the 2025 annual accounts, filed on 09-09-2026
Director (not named in the articles)
since 04-04-2018
listed in the 2025 annual accounts, filed on 09-09-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 17-01-2024
Mandates through the years
2 names, the dashed line is todayBoard
Board
Board
Mandates as a list
-
- Board, from 04-04-2018 to date
-
- Board, from 04-04-2018 to date
Control
Founders
,
This company
GENEPLAZA
Equity -€7,906
Profit €4,743 in 2025
Capital
- Contribution
- €18,600
- Shares
- 18,600
- Contribution per share
- €1
- Equity per share
- -€0.43 in 2025
- Source
- deed of 17-01-2024
Articles of association
deed of 17-01-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of June at 19:00
Shareholders
At incorporation
deed of 06-04-2018 ↗
- 7,440 shares (40%)
- 11,160 shares (60%)
Capital transactions
Capital over time
- 17-01-2024 Converted to unavailable equity · €18,600
- 06-04-2018 Incorporation · €18,600 · 18,600 shares